Six Ways To Get The Most Out Of Outsourcing In Clinical Trials West Coast ‘17
There’s only a couple of weeks to go until Arena’s flagship event, Outsourcing in Clinical Trials West Coast returns to Burlingame. The must-attend event brings
The FDA Is Knocking At Your Door – Are You Ready For An FDA Site Inspection?
Are you ready for an FDA site inspection? You may have heard that CluePoints signed an agreement with the FDA. This Cooperative Research and Development Agreement(CRADA)
Webinar: Risk-Based Monitoring Implementation – What Does ICH E6 Rev2 Mean For My Company?
With the official publication of the long awaited revision of the ICH E6 Guidelines, now is the time to take advantage of the new information to
CluePoints Answers Your Risk-Based Monitoring Implementation Questions
Q1) Are the indicators percentages? E.g., % AEs for the site v study or just number (which could indicate that there are many AEs as
Risk-Based Monitoring Insights From The Industry: Angie Maurer
Part Seven In the latest of our eight-part ‘Insights from the Industry’ series, we caught up with Angie Maurer, Co-Founder & CEO at Zynapsys. Here’s what
Risk-Based Monitoring Insights From The Industry: Jamie O’Keefe
Part Six In the latest of our eight-part Q&A series, we catch up with Jamie O’Keefe, Vice President, Life Sciences, and R&D Practice at Paragon Solutions to
Risk-Based Monitoring Insights From The Industry: Steve Young
Part Five We’ve heard some great insights on the current hot topics in Risk-Based Monitoring (RBM) from a number of leading experts over recent weeks.
Defining Clinical Trial Thresholds: Objective Vs Subjective?
Over the past few weeks, we’ve been discussing the thoughts of some of the leading experts in Risk-Based Monitoring, and we’ve really appreciated those of
Central Statistical Monitoring Should Support Key Risk Indicators
As you may well know, much of the early work in Risk-Based Monitoring has focused on relatively simple Key Risk Indicators (KRIs) and traffic-light dashboards, which are
Are The Regulatory Authorities Ready For The Adoption Of Risk-Based Monitoring?
Firstly, thanks to those of you who got involved with our recent discussion about current best practice in Risk-Based Monitoring, it was great to hear
